What is a good control group?

International Journal for Ion Mobility Spectrometry

Volumn 16, Issue 3, 2013, Pages 191-198

  Cumeras, R ^a,b   Figueras, E ^a   Gracia I ^a   Maddula, S ^b,c   Baumbach, J I ^b,c  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Korea Institute of Science and Technology Europe (KIST Europe)   (Germany)

^c TU DORTMUND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84880272386     PISSN: 14356163     EISSN: 18654584     Source Type: Journal    
DOI: 10.1007/s12127-012-0116-y     Document Type: Article

References (55)

1. Ligor M et al (2009) Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry. Clin Chem Lab Med 47(5): 550-560.
2. Buszewski B et al (2009) Analysis of exhaled breath from smokers, passive smokers and non-smokers by solid-phase microextraction gas chromatography/mass spectrometry. Biomed Chromatogr 23(5): 551-556.
3. Ligor T et al (2008) The analysis of healthy volunteers' exhaled breath by the use of solid-phase microextraction and GC-MS. J Breath Res 2: 1-8.
4. Schubert JK et al (2007) Determination of antibiotic drug concentrations in circulating human blood by means of solid phase micro-extraction. Clin Chim Acta 386(1-2): 57-62.
5. Smith D et al (2010) Isoprene levels in the exhaled breath of 200 healthy pupils within the age range 7-18 years studied using SIFT-MS. J Breath Res 4: 1-7.
6. Enderby B et al (2009) Concentrations of some metabolites in the breath of healthy children aged 7-18 years measured using selected ion flow tube mass spectrometry (SIFT-MS). J Breath Res 3: 1-11.
7. Spanel P, Smith D (2008) Quantification of trace levels of the potential cancer biomarkers formaldehyde, acetaldehyde and propanol in breath by SIFT-MS. J Breath Res 2: 1-10.
8. Spanel P, Dryahina K, Smith D (2007) The concentration distributions of some metabolites in the exhaled breath of young adults. J Breath Res 1: 1-8.
9. Dryahina K, Polasek M, Spanel P (2004) A selected ion flow tube, SIFT, study of the ion chemistry of H3O+, NO+ and O2+• ions with several nitroalkanes in the presence of water vapour. Int J Mass Spectrom 239: 57-65.
10. Thekedar B et al (2009) Investigations on the variability of breath gas sampling using PTR-MS. J Breath Res 3: 1-11.
11. Schwarz K, Filipiak W, Amann A (2009) Determining concentration patterns of volatile compounds in exhaled breath by PTR-MS. J Breath Res 3: 1-15.
12. Wisthaler A (2004) PTR-MS: a new tool for the rapid detection and quantification of VOCs in air at ultra-trace levels. Institut für Ionenphysik, Leopold-Franzens-Universität Innsbruck, Innsbruck.
13. Lindinger W, Hansel A, Jordan A (1998) On-Line Monitoring of Volatile Organic Compounds at pptv Levels by Means of Proton-Transfer-Reaction Mass Spectrometry (PTR-MS). - Medical Applications, Food Control and Environmental Research. Int J Mass Spectrom Ion Process 173: 191-241.
14. Lindinger W, Hansel A, Jordan A (1998) Proton-transfer-reaction mass spectrometry (PTR-MS): on-line monitoring of volatile organic compounds at pptv levels. Chem Soc Rev 27: 347-354.
15. Baumbach JI (2006) Process analysis using ion mobility spectrometry. Anal Bioanal Chem 384(5): 1059-1070.
16. Jünger M, Bödeker B, Baumbach JI (2010) Peak assignment in multi-capillary column - ion mobility spectrometry using comparative studies with gas chromatography - mass spectrometry for exhalred breath analysis. Anal Bioanal Chem 396(1): 471-482.
17. Maddula S et al (2009) Detection of volatile metabolites of Escherichia coli by multi capillary column coupled ion mobility spectrometry. Anal Bioanal Chem 394(3): 791-800.
18. Baumbach JI (2009) Ion mobility spectrometry coupled with multi-capillary columns for metabolic profiling of human breath. J Breath Res 3: 1-16.
19. Bödeker B, Vautz W, Baumbach JI (2008) Peak comparison in MCC/IMS - data - searching for potential biomarkers in human breath data. Int J Ion Mobil Spectrom 11(1): 89-93.
20. Baumbach JI, Westhoff M (2006) Ion mobility spectrometry to detect lung cancer and airway infections. Spectrosc Eur 18(6): 22-27.
21. 2. Phys Rev 178(1): 234-239.
22. Harden CS (2004) Ion mobility spectrometry for detection of chemical warfare agents 1960's to the present. Int J Ion Mobil Spectrom 7(1): 30-37.
23. Li F et al (2001) UV-ion mobility spectrometer coupled to mass spectrometer. Int J Ion Mobil Spectrom 4(2): 100-103.
24. Bowers WD et al (1981) Trace impurities in solvents commonly used for gas-chromatographic analysis of environmental-samples. J Chromatogr 206(2): 279-288.
25. Eiceman GA, Clement RE, Karasek FW (1979) Analysis of fly-ash from municipal incinerators for trace organic-compounds. Anal Chem 51(14): 2343-2350.
26. Smiths Detection. CAM and IONSCAN. [cited 2008 1 Feb.]; Available from: http://www. smithsdetection. com/.
27. Ewing RG et al (2001) A critical review of ion mobility spectrometry for the detection of explosives and explosive related compounds. Talanta 54(3): 515-529.
28. Webster G (2001) Evolution of IMS technology within the Australian Customs Service. Int J Ion Mobil Spectrom 4(1): 65-66.
29. Keller T et al (1999) Ion mobility spectrometry for the detection of drugs in cases of forensic and criminalistic relevance. Int J Ion Mobil Spectrom 2(1): 22-34.
30. Kanu AB, Hill HH Jr (2007) Identity confirmation of drugs and explosives in ion mobility spectrometry using a secondary drift gas. Talanta 73(4): 692-699.
31. Kudriavtseva S et al (2004) Detection of drugs of abuse in sweat using ion trap mobility spectrometry. Int J Ion Mobil Spectrom 7(2): 39-46.
32. Rasulev UK et al (2001) Atmosphere pressure surface ionization indicator of narcotics. Int J Ion Mobil Spectrom 4(2): 121-125.
33. Keller T et al (1998) Detection of methamphetamine, MDMA and MDEA in human hair by means of ion mobility spectrometry (IMS). Int J Ion Mobil Spectrom 1(1): 38-42.
34. Ruzsanyi V et al (2005) Detection of human metabolites using multi-capillary columns coupled to ion mobility spectrometers. J Chromatogr A 1084(1-2): 145-151.
35. Ells B et al (2000) Trace level determination of perchlorate in water matrices and human urine using ESI-FAIMS-MS. J Environ Monitor 2(5): 393-397.
36. Baumbach JI et al (2010) Breath discovery based on ion mobility spectrometry and classification and differentiation models for lung diseases. Biomed Tech 55(Suppl. 1): 1-249.
37. Karpas Z et al (2002) Diagnosis of vaginal infections by ion mobility spectrometry. Int J Ion Mobil Spectrom 5(3): 49-54.
38. Daviss B (2005) Growing pains for metabolomics. The Scientist 19(8): 25-28.
39. Smedsgaard J, Nielsen J (2005) Metabolite profiling of fungi and yeast: from phenotype to metabolome by MS and informatics. J Exp Bot 56(410): 273-286.
40. Maddula S (2005) Volatile metabolite fingerprints of Escherichia coli, in Dept. of biochemical and chemical engineering. University Dortmund, Dortmund, p 52.
41. Griffin JL, Kauppinen RA (2007) Tumor metabolomics in animal models of human cancer. J Proteome Res 6(2): 498-505.
42. Davies AN, Baumbach JI (2008) Early lung cancer diagnostics by ion mobility spectrometry data handling. Spectrosc Eur 20(5): 18-21.
43. Westhoff M et al (2010) Differentiation of chronic obstructive pulmonary disease (COPD) including lung cancer from healthy control group by breath analysis using ion mobility spectrometry. Int J Ion Mobil Spectrom 13(3-4): 131-139.
44. Bader S (2005) Atemluftüberwachung mittels mikrostrukturierter Ionenbeweglichkeitsspektrometrie: Statistische Analyse zum Auffinden von Biomarkern für Lungenkrebs. In: Fachbereich Statistik. Universität Dortmund, Dortmund, p 113.
45. Kreuder AE et al (2011) Characterization of propofol in human breath of patients undergoing anesthesia. Int J Ion Mobil Spectrom 14(4): 167-175.
46. Perl T et al (2009) Determination of serum propofol concentrations by breath analysis using ion mobility spectrometry. Br J Anaesth 103(6): 822-827.
47. Mosby's Medical Dictionary, 8th ed. (2009) St Louis, MO, Mosby/Elsevier.
48. ICH Harmonised Tripartite Guideline, Choice of Control Group and Related Issues in Clinical Trials (ICH-E10), in international conference on harmonisation of technical requirements for registration of pharmaceuticals for human use.
49. European Medicine Agency (EMA). Regulatory. Human medicines. Secientific guidelines. ICH guidelines. [cited 2012 5th Dec]; Available from: http://www. emea. europa. eu/ema/index. jsp?curl=pages/regulation/general/general_content_000035. jsp&mid=WC0b01ac0580027645.
50. Pharmaceuticals and Medical Devices Agency (PDMA). International Conference on harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. [cited 2012 5th Dec]; Available from: http://www. pmda. go. jp/ich/ich_index. html.
51. Food and Drug Administration (FDA). Regulatory Information. Import and Export Guidance Documents. [cited 2012 5th Dec]; Available from: http://www. fda. gov/RegulatoryInformation/Guidances/ucm122048. htm.
52. Bödeker B, Baumbach J (2009) Analytical description of IMS-signals. Int J Ion Mobil Spectrom 12(3): 103-108.
53. Bödeker B, Vautz W, Baumbach JI (2008) Peak Finding and Referencing in MCC/IMS - Data. Int J Ion Mobil Spectrom 11(1-4): 83-88.
54. Bödeker B, Vautz W, Baumbach JI (2008) Visualisation of MCC/IMS - Data. Int J Ion Mobil Spectrom 11(1): 77-82.
55. Cumeras R et al (2012) Stability and alignment of MCC/IMS devices. Int J Ion Mobil Spectrom 15(1): 41-46.